Q3 2019 Collegium Pharmaceutical Inc Earnings Call
Conference Call Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc Conference call will be held on Nov 7, 2019. During the earnings conference call's session Collegium Pharmaceutical Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Collegium Pharmaceutical Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a specialty pharmaceutical company developing and planning to commercialize nextgeneration abusedeterrent products that incorporate our patented DETERx® platform technology for the treatment of chronic pain and other diseases. Our lead product candidate, Xtampza ER(TM) , or Xtampza, is an abusedeterrent, extendedrelease, oral formulation of oxycodone, a widely prescribed opioid medication. On November 6, 2015, the U.S. Food and Drug Administration, or FDA, granted tentative approval to the new drug application, or NDA, for Xtampza for the management of pain severe enough to require daily, aroundtheclock, longterm opioid treatment and for which alternative treatment options are inadequate.Read more Conference Call